𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HOW TO EXPAND THE ‘SAMPLE SIZE’ OF STUDIES OF DRUG MARKET DISRUPTIONS

✍ Scribed by JONATHAN CAULKINS


Book ID
108598649
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
76 KB
Volume
104
Category
Article
ISSN
0965-2140

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The study of candidate genes in drug tri
✍ Robert C. Elston; Ramana M. Idury; Lon R. Cardon; Jay B. Lichter 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

With discovery of an increasing number of candidate genes that may affect inter-individual variability in response to drugs, the design of drug trials that incorporate their study has become relevant. We discuss the determination of sample size for such studies when the number of tests to perform is

Pharmacodynamics as a tool to assess the
✍ Patrick Du Souich; Jean-Guy Besner; Gilles Caille 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

## Abstract Bioequivalence studies of drugs which are not systematically available must rely on the measure of the pharmacological response. Detection of a difference between two such preparations is often hampered by the need to include an elevated number of subjects. The number of subjects can be

Optimizing the power of genome-wide asso
✍ Joanna J. Zhuang; Krina Zondervan; Fredrik Nyberg; Chris Harbron; Ansar Jawaid; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract Genome‐wide association (GWA) studies have proved extremely successful in identifying novel genetic loci contributing effects to complex human diseases. In doing so, they have highlighted the fact that many potential loci of modest effect remain undetected, partly due to the need for sa